We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+12.37%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$11.2B
AUM Growth
+$4.26B
Cap. Flow
+$3.37B
Cap. Flow %
30.06%
Top 10 Hldgs %
50.61%
Holding
1,169
New
360
Increased
131
Reduced
115
Closed
294
Avg Time Held Equity + Options
1.3 quarters
Top 10 Avg Time Held Equity + Options
0.9 quarters
Top 20 Avg Time Held Equity + Options
0.9 quarters
Avg Time Held Equity only
1.2 quarters
Top 10 Avg Time Held Equity only
0.9 quarters
Top 20 Avg Time Held Equity only
0.9 quarters

Top Buys

Rank Stock Value
1
PPD
PPD, Inc. Common Stock
PPD
+$645M
2
NUAN
Nuance Communications, Inc.
NUAN
+$539M
3
MXIM
Maxim Integrated Products
MXIM
+$525M
4
VER
VEREIT, Inc.
VER
+$520M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$491M

Top Sells

Rank Stock Value
1
VAR
Varian Medical Systems, Inc.
VAR
+$475M
2
RP
RealPage, Inc.
RP
+$281M
3
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
+$209M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$170M
5
CLGX
Corelogic, Inc.
CLGX
+$160M

Sector Composition

Rank Sector Weight
1 Technology 26.69%
2 Healthcare 19.01%
3 Financials 14.31%
4 Real Estate 10.94%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
LJAQW
751
DELISTED
LightJump Acquisition Corporation Warrant
LJAQW
$137K ﹤0.01%
174,994
– –
2021 Q1
1 quarter
PACXW
752
DELISTED
Pioneer Merger Corp. Warrant
PACXW
$136K ﹤0.01%
83,330
– –
2021 Q1
1 quarter
CYXTW
753
DELISTED
Cyxtera Technologies, Inc. Warrant
CYXTW
$136K ﹤0.01%
66,664
– –
2021 Q1
1 quarter
CBAH.WS
754
DELISTED
CBRE Acquisition Holdings, Inc. Warrants, each whole warrant exercisable for one share of Class A co
CBAH.WS
$136K ﹤0.01%
124,996
– –
2021 Q1
1 quarter
ACKIW
755
DELISTED
Ackrell SPAC Partners I Co Warrants
ACKIW
$134K ﹤0.01%
212,690
+50,196
+31% +$28.6K
2021 Q1
1 quarter
DAL icon
756
PUT
Delta Air Lines
DAL
$52.7B
$132K ﹤0.01%
+20,000
New +$926K
2021 Q2
0 quarters
XRX icon
757
PUT
Xerox
XRX
$356M
$132K ﹤0.01%
+30,600
New +$740K
2021 Q2
0 quarters
TLGA.WS
758
DELISTED
TLG Acquisition One Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
TLGA.WS
$132K ﹤0.01%
166,660
– –
2021 Q1
1 quarter
M icon
759
PUT
Macy's
M
$6B
$131K ﹤0.01%
+36,500
New +$648K
2021 Q2
0 quarters
PV.WS
760
DELISTED
Primavera Capital Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PV.WS
$130K ﹤0.01%
124,996
– –
2021 Q1
1 quarter
KWAC.WS
761
DELISTED
Kingswood Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common
KWAC.WS
$129K ﹤0.01%
187,493
– –
2021 Q1
1 quarter
ADEX.WS
762
DELISTED
Adit EdTech Acquisition Corp Warrants
ADEX.WS
$128K ﹤0.01%
187,493
– –
2021 Q1
1 quarter
ANAC.WS
763
DELISTED
Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ANAC.WS
$128K ﹤0.01%
+125,098
New +$107K
2021 Q2
0 quarters
NGL icon
764
PUT
NGL Energy Partners
NGL
$1.83B
$126K ﹤0.01%
+148,700
New +$333K
2021 Q2
0 quarters
DISAW
765
DELISTED
Disruptive Acquisition Corporation I Warrant
DISAW
$126K ﹤0.01%
+139,711
New +$134K
2021 Q2
0 quarters
SRZNW icon
766
DELISTED
Surrozen Inc Warrant
SRZNW
$125K ﹤0.01%
83,330
+54
+0.1% +$59
2021 Q1
1 quarter
THCPU icon
767
DELISTED
Thunder Bridge Capital Partners IV, Inc. Unit
THCPU
$125K ﹤0.01%
+12,634
New +$125K
2021 Q2
0 quarters
NAVI icon
768
PUT
Navient
NAVI
$868M
$124K ﹤0.01%
+191,500
New +$3.29M
2021 Q2
0 quarters
ADT icon
769
PUT
ADT
ADT
$4.71B
$122K ﹤0.01%
+56,800
New +$571K
2021 Q2
0 quarters
CXAIW icon
770
CXApp Inc Warrant
CXAIW
$575K
$122K ﹤0.01%
149,994
– –
2021 Q1
1 quarter
EUSGW
771
DELISTED
European Sustainable Growth Acquisition Corp. Warrant
EUSGW
$122K ﹤0.01%
124,996
– –
2021 Q1
1 quarter
PEARW
772
DELISTED
Pear Therapeutics, Inc. Warrant
PEARW
$120K ﹤0.01%
83,330
– –
2021 Q1
1 quarter
SABSW icon
773
SAB Biotherapeutics Warrant
SABSW
$97.5K
$116K ﹤0.01%
124,996
– –
2021 Q1
1 quarter
EACPW
774
DELISTED
Edify Acquisition Corp. Warrant
EACPW
$116K ﹤0.01%
174,994
– –
2021 Q1
1 quarter
FCAX.WS
775
DELISTED
Fortress Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
FCAX.WS
$116K ﹤0.01%
99,996
– –
2021 Q1
1 quarter
29 30
31
32 33

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q2 2021 Portfolio in Review

As of Q2 2021, UBS O'Connor held 1,169 positions worth $11.2B, up 61% from $6.94B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

UBS O'Connor deployed $3.37B of net new capital in Q2 2021, opening 360 new positions and adding to 131 existing holdings. Its largest new stake was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was MasTec, an estimated $7.65M trimmed.

  • UBS O'Connor's largest Q2 2021 buy was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.
  • UBS O'Connor added most to Maxim Integrated Products in Q2 2021, an estimated $525M increase.
  • UBS O'Connor's biggest Q2 2021 reduction was MasTec, cutting an estimated $7.65M.
  • UBS O'Connor fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $475M.
  • UBS O'Connor's ten largest holdings make up 51% of its $11.2B portfolio in Q2 2021.
  • UBS O'Connor opened 360 new positions and closed 294 in Q2 2021.
  • UBS O'Connor's portfolio value rose 61% quarter-over-quarter to $11.2B.

Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.